Choose Language
Select a language for news translation.
Written by Prosper Junior Bakiny for The Motley Fool -> Revolution Medicines has a promising cancer drug in development. Even with this medicine's prospects,…
Written by Thomas Niel for The Motley Fool -> After reporting an earnings beat last quarter, AbbVie could once again beat expectations in the second quarter, …
Written by Jake Lerch for The Motley Fool -> State Street Health Care Select Sector SPDR ETF maintains a significantly lower expense ratio of 0.08% compared t…
Written by Jake Lerch for The Motley Fool -> State Street Health Care Select Sector SPDR ETF has a much lower expense ratio and significantly higher assets un…
Vanguard’s VHT offers lower fees and double the dividend yield of Invesco’s IBBQ through broader healthcare exposure. This makes VHT a cost-effective choice fo…
The State Street Health Care Select Sector SPDR ETF is preferred over the VanEck Pharmaceutical ETF due to its lower expense ratio and broader diversification …
The VanEck Pharmaceutical ETF (PPH) targets 25 pharmaceutical companies, while the State Street Health Care Select Sector SPDR ETF (XLV) includes 60 positions …
Written by Thomas Niel for The Motley Fool -> AbbVie's shift towards immunology treatments points to continued dividend growth for this pharmaceutical stock. …
Written by Sara Appino for The Motley Fool -> iShares Global Healthcare ETF provides lower-cost exposure to the broader medical sector than iShares Biotechnol…
Vanguard Health Care ETF (NYSEMKT:VHT) provides broad-based sector coverage with a significantly lower expense ratio, while iShares U.S. Pharmaceuticals ETF (N…
Investors choosing between iShares Global Healthcare ETF (NYSEMKT:IXJ) and Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) may weigh broad global diversificatio…
